Top Markets
#1 Islamic Coin Islamic Coin +151.57%
#2 Black Phoenix Black Phoenix +26.23%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.62%
#4 Fake World Assets Fake World Assets +15.66%
#5 OpenEden OpenEden +13.12%
#6 clBTC clBTC +12.10%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.63%
#8 Pons Pons +10.75%
#9 Akedo Akedo +9.52%
#10 TENDIES TENDIES +9.06%
Coin of the day
Islamic Coin Islamic Coin
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Nabriva Therapeutics plc Nabriva Therapeutics plc

Nabriva Therapeutics plc

NBRV
Hisse Senetlerindeki Sıralama #39979
Nabriva Therapeutics plc is a biopharmaceutical company focused on the... Nabriva Therapeutics plc is a biopharmaceutical company focused on the discovery and commercialization of innovative anti-infective medications to combat serious infections. The company's current marketed products include SIVEXTRO, an oxazolidinone-class antibacterial designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and XENLETA, a semi-synthetic pleuromutilin antibiotic utilized in managing community-acquired bacterial pneumonia. Beyond its existing offerings, Nabriva is further exploring XENLETA's potential in Phase I clinical trials for a broad spectrum of indications, such as pediatric infections, sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated and hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. Additionally, the firm is developing CONTEPO, an epoxide antibiotic for complicated urinary tract infections, which is also undergoing Phase I clinical evaluation for peri-operative prophylaxis. Originally incorporated in 2005 as Nabriva Therapeutics Forschungs GmbH, the company rebranded to Nabriva Therapeutics plc in 2007 and maintains its corporate headquarters in Dublin, Ireland.
Hisse Fiyatı
$0.63
Son senkronizasyon: 2023-08-29
Piyasa Değeri
$284.20K
Değişim (1 gün)
-21.25%
Değişim (1 yıl)
0.00%
Ülke
IE
Ticaret Nabriva Therapeutics plc (NBRV)

Kategori

Healthcare
Nabriva Therapeutics plc (NBRV) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.72 - 2023-08-01

Gün sonu en düşük fiyat: $2.65K - 2015-09-01
Nabriva Therapeutics plc için hisse fiyatı geçmişi: 2015 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2023 -62.69%
2022 -88.16%
2021 -77.92%
2020 -82.12%
2019 -3.21%
2018 -70.79%
2017 19.90%
2016 -48.03%
2015 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 9.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.27%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 14.81%
BE